Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Xanthouli (Heidelberg, Germany), M. Kögler (Heidelberg, Germany), A. Marra (Naples, Italy), N. Benjamin (Heidelberg, Germany), L. Fischer (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), C. Nagel (Heidelberg, Germany), E. Grünig (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany). Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities. 1520

Member's Comments

No comment yet.

Related content which might interest you: Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Risk stratification and medical therapy of pulmonary arterial hypertension Source: Eur Respir J, 53 (1) 1801889; 10.1183/13993003.01889-2018 Year: 2019 Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017 Year: 2018 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Prognostic risk factors of disease worsening in patients with functional class II pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 342s Year: 2007 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Prognostic factors in surgically-treated chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Prognostic factors in non-surgical chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin Source: Eur Respir J 2015; 46: 1701-1710 Year: 2015 Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 332-338 Year: 2009 Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018 Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018 Year: 2018 Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017 Year: 2018 Risk assessment in pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 390-398 Year: 2016 The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013